Kathleen Uhl MD
Kathleen (Cook) Uhl, M.D. serves as the Acting Director for the Office of Generic Drugs in the Center for Drug Evaluation and Research. This office is responsible for the review and approval of Abbreviated New Drug Applications (ANDAs).
Its mission is to ensure, through a scientific and regulatory process, that generic drugs are safe and effective for the American public.